Farmaceutica R (RMAH) — Defensive Interval Ratio
Farmaceutica R (RMAH) has a Defensive Interval Ratio of 250 days as of December 2025. Defensive assets of RON203.88 Million (cash RON-, short-term investments RON-, receivables RON203.88 Million) cover 250 days of daily cash needs of RON817.12K/day. See RMAH working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Farmaceutica R Defensive Interval Ratio (2020–2025)
This chart shows how Farmaceutica R's Defensive Interval Ratio has evolved across 6 annual periods from 2020 to 2025. As of December 2025, the ratio stands at 250 days, meaning defensive assets of RON203.88 Million can fund 250 days of operations without new revenue. See RMAH net asset quality score to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for Farmaceutica R (2020–2025)
The table below presents the year-by-year Defensive Interval Ratio for Farmaceutica R from 2020 to 2025, covering 6 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see RMAH market cap overview.
| Year | DIR (days) | Defensive Assets (RON) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 250 days | RON203.88 Million | RON817.12K/day | RON- | RON- | ▼ -18 days |
| 2024 | 268 days | RON216.95 Million | RON810.67K/day | RON- | RON- | ▼ -13 days |
| 2023 | 281 days | RON184.26 Million | RON656.04K/day | RON- | RON- | ▼ -15 days |
| 2022 | 295 days | RON173.70 Million | RON587.93K/day | RON- | RON- | ▲ +17 days |
| 2021 | 279 days | RON137.63 Million | RON493.99K/day | RON- | RON- | ▼ -14 days |
| 2020 | 293 days | RON130.20 Million | RON444.89K/day | RON- | RON- | — |